International ClinicsMedical News
International Clinics Newsroom · · 2 min read
Daily

Australia's TGA approves the first weight-loss pill, oral semaglutide (Wegovy)

  • Australia's Therapeutic Goods Administration has approved a once-daily oral tablet form of semaglutide, sold as Wegovy.
  • It is registered in 1.5 mg, 4 mg, 9 mg and 25 mg strengths for chronic weight management and to reduce cardiovascular risk in eligible adults.
  • The TGA advises against combining Wegovy tablets or injections with other semaglutide products or other GLP-1 drugs.
  • The tablet is not yet available in Australia, and it has no subsidy on the Pharmaceutical Benefits Scheme.
White tablets on a dark reflective surface
White tablets on a dark reflective surface Photo: newsGP / RACGP
Published:

Australia's medicines regulator, the Therapeutic Goods Administration (TGA), has approved the country's first weight-loss pill: a once-daily oral tablet form of semaglutide sold as Wegovy. According to newsGP, the publication of the Royal Australian College of General Practitioners, the approval was granted on Tuesday 3 November 2026.

What was approved

The tablet is registered in 1.5 mg, 4 mg, 9 mg and 25 mg strengths. A TGA spokesperson said its indications, chronic weight management and reducing the risk of major adverse cardiovascular events in eligible adults, match those of the injectable Wegovy. The TGA warned that using Wegovy tablets or injections together with other semaglutide-containing products or any other GLP-1 receptor agonist is not recommended.

Also read: EMA recommends Foundayo (orforglipron), a once-daily GLP-1 tablet for obesity and type 2 diabetes

How it is taken

Because semaglutide is poorly absorbed from the gut, the tablet must be swallowed on an empty stomach with a sip of water on waking, followed by a 30-minute wait before eating, drinking or taking other oral medicines, according to the US product information.

Access questions

RACGP President Dr Michael Wright called the approval "a step forward" for patients who avoid injections, but stressed that GLP-1 medicines can have serious side effects and are best prescribed by a regular GP alongside advice on diet and exercise. Novo Nordisk says it expects availability later this year. The tablet is not subsidised, and injectable Wegovy is also still not listed on the Pharmaceutical Benefits Scheme despite a recommendation almost a year ago.

Data cited by newsGP suggest about 1.6 million Australians bought a GLP-1 medicine privately in the past 12 months.

Source: newsGP (RACGP)

This story is relayed from the source named above; responsibility for its content rests with the original source.

FAQ

Has Australia approved a weight-loss pill?

Yes. Australia's Therapeutic Goods Administration approved an oral once-daily tablet form of semaglutide, sold as Wegovy, in November 2026.

What doses of the Wegovy pill were approved in Australia?

The TGA registered Wegovy tablets in 1.5 mg, 4 mg, 9 mg and 25 mg strengths.

How should the Wegovy pill be taken?

According to US product information, the Wegovy tablet is taken on waking on an empty stomach with a sip of water, followed by a 30-minute wait before eating, drinking or taking other oral medicines.

Can Wegovy tablets be combined with other GLP-1 drugs?

No. The TGA says using Wegovy tablets or injections together with other semaglutide products or other GLP-1 receptor agonists is not recommended.

Is the Wegovy pill subsidised in Australia?

No. The Wegovy pill is not subsidised in Australia, and injectable Wegovy is also not yet listed on the Pharmaceutical Benefits Scheme.

How would you rate this story?
1,625
Latest news
A fluoride-free gel that may rebuild tooth enamel, from the University of Nottingham Jackson 5's Marlon Jackson reveals he has lived with prostate cancer for four years Tip of the day: get your flu vaccine early, before winter peaks Every plant-based food in a UK study contained fungal toxins, all within EU guideline levels Tip of the day: spit, don't rinse, after brushing your teeth Energy drinks appear 11 times more often in cardiac arrest reports, preliminary study finds ISAPS global survey: eyelid surgery leads, breast lift grows fastest and filler declines Hippocrates: "Life is short, and Art long" Born on this day: William Beaumont and the hole in a stomach that rewrote digestion Tip of the day: sleep at least 7 hours a night, on a regular schedule
The latest-news bar is closed. You can bring it back any time with the “Latest news” button in the menu.